Drew Kern
Co-Director, Advanced Therapies for Movement Disorders Program · University of Colorado School of Medicine
Credentials: · · · · ·
History
PresentAdvanced Therapies for Movement Disorders Program · University of Colorado School of Medicine
- 2014–2015
- 2010–2013
- 2010–2013
- 2009–2010
Research
Preclinical and clinical evaluation of the LRRK2 inhibitor DNL201 for Parkinson's disease
Science Translational Medicine · 2022 · 199 citations
Colonic mucosal a-synuclein lacks specificity as a biomarker for Parkinson disease
Neurology · 2015 · 120 citations
Long-term activity in upper- and lower-limb muscles of humans
Journal of Applied Physiology · 2001 · First of 3 authors · 99 citations
22 papers
14 papers
9 papers · 3 as a fellow
8 papers
- AT
4 papers
4 papers · 4 as a fellow
4 papers
4 papers · 2 as a fellow
Clinical trials
- 2017–2023
Stimulation of the Rostral Zona Incerta for Parkinson's Disease
Principal investigator · Completed
University of Colorado, Denver
- 2024–2025
Adaptive DBS to Offset STN Dysregulation During Exercise in PD
Site PI · Recruiting
University of Colorado, Denver
- 2022–2027